NCT02531958

Brief Summary

Recently, the United States Department of Agriculture (USDA) has recommended removal of the 300mg/day limit on dietary cholesterol intake due to a lack of evidence supporting a connection between cholesterol intake and increased risk for cardiovascular disease (CVD). Previous work has shown that daily intake of eggs actually favorably alters many parameters associated with CVD risk. Conversely, emerging research suggests that choline, a nutrient in eggs, may be converted into trimethylamine oxide (TMAO) by the intestinal microbiota. TMAO is thought to increase the risk for CVD. Therefore, the purpose of this study is to determine a threshold of daily egg intake at which the risk for CVD is not negatively impacted in a young, healthy population.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 14, 2015

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

August 20, 2015

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 25, 2015

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 18, 2015

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2017

Completed
Last Updated

June 27, 2017

Status Verified

June 1, 2017

Enrollment Period

4 months

First QC Date

August 20, 2015

Last Update Submit

June 23, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Plasma high-density lipoprotein (HDL)

    Plasma HDL (in mg/dL) will be measured at 2, 6, 10, and 14 weeks to determine the impact of daily egg intake on HDL

    14 Weeks

Secondary Outcomes (1)

  • Plasma trimethylamine oxide (TMAO)

    14 Weeks

Study Arms (3)

1 Egg

EXPERIMENTAL

Consumption of 1 egg per day for 4 weeks

Other: Eggs

2 Eggs

EXPERIMENTAL

Consumption of 2 eggs per day for 4 weeks

Other: Eggs

3 Eggs

EXPERIMENTAL

Consumption of 3 eggs per day for 4 weeks

Other: Eggs

Interventions

EggsOTHER

Participants will complete a 2-week washout period followed by intake of 1, 2, and 3 eggs per day for 4 weeks each.

1 Egg2 Eggs3 Eggs

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • BMI 18.5-29.9 kg/m2
  • Proficient in English
  • Cholesterol ≤ 240 mg/dL
  • Willing to consume 1, 2, and 3 eggs per day for 4 weeks each

You may not qualify if:

  • Diabetes mellitus, cardiovascular disease, history of stroke, renal disease, liver disease, cancer, or eating disorder
  • Taking glucose-lowering supplements or medications
  • Taking triglyceride-lowering medications, bile acid sequestrants, or high-dose chromium or cinnamon supplements
  • Plasma glucose \< 126 mg/dL, triglycerides \> 500 mg/dL, or blood pressure \> 140/90 mmHg (average of 3 readings)
  • Allergy to eggs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Connecticut

Storrs, Connecticut, 06269, United States

Location

Related Publications (1)

  • DiMarco DM, Norris GH, Millar CL, Blesso CN, Fernandez ML. Intake of up to 3 Eggs per Day Is Associated with Changes in HDL Function and Increased Plasma Antioxidants in Healthy, Young Adults. J Nutr. 2017 Mar;147(3):323-329. doi: 10.3945/jn.116.241877. Epub 2017 Jan 11.

MeSH Terms

Conditions

Cardiovascular Diseases

Interventions

Eggs

Intervention Hierarchy (Ancestors)

FoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • Maria Luz Fernandez, PhD

    University of Connecticut

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 20, 2015

First Posted

August 25, 2015

Study Start

August 14, 2015

Primary Completion

December 18, 2015

Study Completion

May 31, 2017

Last Updated

June 27, 2017

Record last verified: 2017-06

Locations